FDA Inspection
ACTA Laboratories, Inc.ACTA Laboratories, Inc. – FDA Inspection, Sep 4, 2026
Record Details
This FDA Inspection record concerns ACTA Laboratories, Inc., with an inspection on September 4, 2026, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 04de87c5-e707-4e42-bbd9-2267bff016aa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1334976
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ACTA Laboratories, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 19, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 14, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 30, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ACTA Laboratories, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.